Summary
Thirty-eight patients with biochemically proven Wilson's disease underwent magnetic resonanceimaging (MRI) of the brain as well as neurological examinations. The patients were scanned using spin-echo (SE) sequences; the neurologist was looking for typical symptoms: dysarthria, tremor, ataxia, rigidity/bradykinesia and chorea/dystonia. Pathological MR findings believed secondary to this uncommon inherited disorder of copper metabolism were found in twenty-two subjects. Focal abnormalities were seen in the lenticular, thalamic and caudate nuclei as well as in brain stem and white matter; these lesions were best demonstrated on T2-weighted sequences as hyperintense areas. In eight patients we found diffuse brain atrophy with consecutive widening of the ventricular system. Five subjects showed mild, nineteen severe neurologic deficits. Generally there was no correlation between MR findings and clinical neurological symptoms; the impairment of cell-metabolism causing functional alterations of the brain precedes morphological changes. During treatment with the copper chelator D-penicillamine there seemed to be a phased course of disease. Shortening of T1-relaxation due to paramagnetic influence of copper was not seen; a possible explanation could be intracellular deposition — a proton-electron-dipolar-dipolar-interaction would therefor be impossible.
Similar content being viewed by others
References
Greenfield JG (1984) Greenfield's Neuropathology. Edward Arnold, London
Roach ES, Ford CS, Spudis EV, et al. (1985) Wilson's disease: evoked potentials and computed tomography. J Neurol 232:20–23
Rothfuß WE, Hirsch WC, Malatack J, Bergmann I (1988) Improvement of cerebral CT abnormalities following liver transplantation in a patient with Wilson's disease. J Comput Assist Tomogr 12:138–140
Starosta-Rubinstein S, Young AB, Kluin K, et al. (1987) Clinical assessment of 31 patients with Wilson's disease. Arch. Neurol 44: 365–370
Nadjmi M, Piepgras U, Vogelsang H (1981) Kranielle Computer Tomographie. Thieme, Stuttgart New York
Williams FJ, Walshe JM (1981) Wilson's disease. Brain 104:735–752
Aisen AM, Martel W, Gabrielsen TO, et al. (1985) Wilson's disease of the brain: MR imaging. Radiology 157:137–141
Volder A de, Sindic CJM, Goffinet AM (1988) Effect of D-penicillamine treatement on brain metabolism in Wilson's disease: a case study. J Neurol Neurosurg Psychiatry 51:947–949
Dörnemann H, Petsch R, Braitinger J (1987) MRI bei Morbus Wilson. RÖFO 147:570–571
Lawler GA, Pennock JM, Steiner E, et al. (1983) Nuclear magnetic resonance (NMR) Imaging in Wilson's disease. J Comput Assist Tomogr 7:1–8
Nix WA, Ludwig G, Backmund H (1984) Computertomographische Verlaufsuntersuchungen bei Morbus Wilson. Nervenarzt 55:544–548
Uhlenbrock D, Straube A, Beyer HK, Leopold HC (1985) Kernspintomographie und Computertomographie des Gehirns zum Nachweis des Morbus Wilson. Digit Bilddiagn 55:120–122
Hawkins RA, Mazziotta JC, Phelps ME (1987) Wilson's disease studied with FDG and positron emission tomography. Neurology 37:1707–1711
Haan J de, Grossmann RI, Civitello H, et al. (1987) Highfield magnetic resonance (NMR) Imaging in Wilson's disease. J Comput Tomogr 11:132–135
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Prayer, L., Wimberger, D., Kramer, J. et al. Cranial MRI in Wilson's disease. Neuroradiology 32, 211–214 (1990). https://doi.org/10.1007/BF00589114
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00589114